Literature DB >> 28419251

Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians.

Mi-Ryung Han1, Wei Zheng1, Qiuyin Cai1, Yu-Tang Gao2, Ying Zheng3, Manjeet K Bolla4, Kyriaki Michailidou4, Joe Dennis4, Qin Wang4, Alison M Dunning5, Paul Brennan6, Shou-Tung Chen7, Ji-Yeob Choi8,9, Mikael Hartman10,11, Hidemi Ito12, Artitaya Lophatananon13, Keitaro Matsuo14,15, Hui Miao10, Kenneth Muir13,16, Suleeporn Sangrajrang17, Chen-Yang Shen18,19, Soo Hwang Teo20, Chiu-Chen Tseng21, Anna H Wu21, Cheng Har Yip22, Daehee Kang8,9,23, Yong-Bing Xiang2, Douglas F Easton4,5, Xiao-Ou Shu1, Jirong Long1.   

Abstract

Over the past 20 years, high-penetrance pathogenic mutations in genes BRCA1, BRCA2, TP53, PTEN, STK11 and CDH1 and moderate-penetrance mutations in genes CHEK2, ATM, BRIP1, PALB2, RAD51C, RAD50 and NBN have been identified for breast cancer. In this study, we investigated whether there are additional variants in these 13 genes associated with breast cancer among women of Asian ancestry. We analyzed up to 654 single nucleotide polymorphisms (SNPs) from 6269 cases and 6624 controls of Asian descent included in the Breast Cancer Association Consortium (BCAC), and up to 236 SNPs from 5794 cases and 5529 controls included in the Shanghai Breast Cancer Genetics Study (SBCGS). We found three missense variants with minor allele frequency (MAF) <0.05: rs80358978 (Gly2508Ser), rs80359065 (Lys2729Asn) and rs11571653 (Met784Val) in the BRCA2 gene, showing statistically significant associations with breast cancer risk, with P-values of 1.2 × 10-4, 1.0 × 10-3 and 5.0 × 10-3, respectively. In addition, we found four low-frequency variants (rs8176085, rs799923, rs8176173 and rs8176258) in the BRCA1 gene, one common variant in the CHEK2 gene (rs9620817), and one common variant in the PALB2 gene (rs13330119) associated with breast cancer risk at P < 0.01. Our study identified several new risk variants in BRCA1, BRCA2, CHEK2, and PALB2 genes in relation to breast cancer risk in Asian women. These results provide further insights that, in addition to the high/moderate penetrance mutations, other low-penetrance variants in these genes may also contribute to breast cancer risk.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2017        PMID: 28419251      PMCID: PMC5963497          DOI: 10.1093/carcin/bgx010

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  45 in total

1.  Ten genes for inherited breast cancer.

Authors:  Tom Walsh; Mary-Claire King
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

2.  CHEK2 1100delC variant and breast cancer risk in Caucasians: a meta-analysis based on 25 studies with 29,154 cases and 37,064 controls.

Authors:  Yuan Yang; Fan Zhang; Yang Wang; Sheng-Chun Liu
Journal:  Asian Pac J Cancer Prev       Date:  2012

3.  BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.

Authors:  Fiona Lalloo; Jennifer Varley; Anthony Moran; David Ellis; Lindsay O'dair; Paul Pharoah; Antonis Antoniou; Roger Hartley; Andrew Shenton; Sheila Seal; Barbara Bulman; Anthony Howell; D Gareth R Evans
Journal:  Eur J Cancer       Date:  2006-04-27       Impact factor: 9.162

4.  Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women.

Authors:  Hui Cai; Yong-Bing Xiang; Shimian Qu; Jirong Long; Qiuyin Cai; Jing Gao; Wei Zheng; Xiao Ou Shu
Journal:  Am J Epidemiol       Date:  2011-03-31       Impact factor: 4.897

5.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Authors:  Alfons Meindl; Heide Hellebrand; Constanze Wiek; Verena Erven; Barbara Wappenschmidt; Dieter Niederacher; Marcel Freund; Peter Lichtner; Linda Hartmann; Heiner Schaal; Juliane Ramser; Ellen Honisch; Christian Kubisch; Hans E Wichmann; Karin Kast; Helmut Deissler; Christoph Engel; Bertram Müller-Myhsok; Kornelia Neveling; Marion Kiechle; Christopher G Mathew; Detlev Schindler; Rita K Schmutzler; Helmut Hanenberg
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

6.  Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

Authors:  Wei Zheng; Jirong Long; Yu-Tang Gao; Chun Li; Ying Zheng; Yong-Bin Xiang; Wanqing Wen; Shawn Levy; Sandra L Deming; Jonathan L Haines; Kai Gu; Alecia Malin Fair; Qiuyin Cai; Wei Lu; Xiao-Ou Shu
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

7.  High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.

Authors:  Virginie Bubien; Françoise Bonnet; Veronique Brouste; Stéphanie Hoppe; Emmanuelle Barouk-Simonet; Albert David; Patrick Edery; Armand Bottani; Valérie Layet; Olivier Caron; Brigitte Gilbert-Dussardier; Capucine Delnatte; Catherine Dugast; Jean-Pierre Fricker; Dominique Bonneau; Nicolas Sevenet; Michel Longy; Frédéric Caux
Journal:  J Med Genet       Date:  2013-01-18       Impact factor: 6.318

8.  Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.

Authors:  Marry H Nieuwenhuis; C Marleen Kets; Maureen Murphy-Ryan; Helger G Yntema; D Gareth Evans; Chrystelle Colas; Pal Møller; Frederik J Hes; Shirley V Hodgson; Maran J W Olderode-Berends; Stefan Aretz; Karl Heinimann; Encarna B Gómez García; Fiona Douglas; Allan Spigelman; Susanne Timshel; Noralane M Lindor; Hans F A Vasen
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

9.  A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.

Authors:  Afshan Siddiq; Fergus J Couch; Gary K Chen; Sara Lindström; Diana Eccles; Robert C Millikan; Kyriaki Michailidou; Daniel O Stram; Lars Beckmann; Suhn Kyong Rhie; Christine B Ambrosone; Kristiina Aittomäki; Pilar Amiano; Carmel Apicella; Laura Baglietto; Elisa V Bandera; Matthias W Beckmann; Christine D Berg; Leslie Bernstein; Carl Blomqvist; Hiltrud Brauch; Louise Brinton; Quang M Bui; Julie E Buring; Saundra S Buys; Daniele Campa; Jane E Carpenter; Daniel I Chasman; Jenny Chang-Claude; Constance Chen; Françoise Clavel-Chapelon; Angela Cox; Simon S Cross; Kamila Czene; Sandra L Deming; Robert B Diasio; W Ryan Diver; Alison M Dunning; Lorraine Durcan; Arif B Ekici; Peter A Fasching; Heather Spencer Feigelson; Laura Fejerman; Jonine D Figueroa; Olivia Fletcher; Dieter Flesch-Janys; Mia M Gaudet; Susan M Gerty; Jorge L Rodriguez-Gil; Graham G Giles; Carla H van Gils; Andrew K Godwin; Nikki Graham; Dario Greco; Per Hall; Susan E Hankinson; Arndt Hartmann; Rebecca Hein; Judith Heinz; Robert N Hoover; John L Hopper; Jennifer J Hu; Scott Huntsman; Sue A Ingles; Astrid Irwanto; Claudine Isaacs; Kevin B Jacobs; Esther M John; Christina Justenhoven; Rudolf Kaaks; Laurence N Kolonel; Gerhard A Coetzee; Mark Lathrop; Loic Le Marchand; Adam M Lee; I-Min Lee; Timothy Lesnick; Peter Lichtner; Jianjun Liu; Eiliv Lund; Enes Makalic; Nicholas G Martin; Catriona A McLean; Hanne Meijers-Heijboer; Alfons Meindl; Penelope Miron; Kristine R Monroe; Grant W Montgomery; Bertram Müller-Myhsok; Stefan Nickels; Sarah J Nyante; Curtis Olswold; Kim Overvad; Domenico Palli; Daniel J Park; Julie R Palmer; Harsh Pathak; Julian Peto; Paul Pharoah; Nazneen Rahman; Fernando Rivadeneira; Daniel F Schmidt; Rita K Schmutzler; Susan Slager; Melissa C Southey; Kristen N Stevens; Hans-Peter Sinn; Michael F Press; Eric Ross; Elio Riboli; Paul M Ridker; Fredrick R Schumacher; Gianluca Severi; Isabel Dos Santos Silva; Jennifer Stone; Malin Sund; William J Tapper; Michael J Thun; Ruth C Travis; Clare Turnbull; Andre G Uitterlinden; Quinten Waisfisz; Xianshu Wang; Zhaoming Wang; Joellen Weaver; Rüdiger Schulz-Wendtland; Lynne R Wilkens; David Van Den Berg; Wei Zheng; Regina G Ziegler; Elad Ziv; Heli Nevanlinna; Douglas F Easton; David J Hunter; Brian E Henderson; Stephen J Chanock; Montserrat Garcia-Closas; Peter Kraft; Christopher A Haiman; Celine M Vachon
Journal:  Hum Mol Genet       Date:  2012-09-13       Impact factor: 6.150

10.  Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.

Authors:  Qiuyin Cai; Ben Zhang; Hyuna Sung; Siew-Kee Low; Sun-Seog Kweon; Wei Lu; Jiajun Shi; Jirong Long; Wanqing Wen; Ji-Yeob Choi; Dong-Young Noh; Chen-Yang Shen; Keitaro Matsuo; Soo-Hwang Teo; Mi Kyung Kim; Ui Soon Khoo; Motoki Iwasaki; Mikael Hartman; Atsushi Takahashi; Kyota Ashikawa; Koichi Matsuda; Min-Ho Shin; Min Ho Park; Ying Zheng; Yong-Bing Xiang; Bu-Tian Ji; Sue K Park; Pei-Ei Wu; Chia-Ni Hsiung; Hidemi Ito; Yoshio Kasuga; Peter Kang; Shivaani Mariapun; Sei Hyun Ahn; Han Sung Kang; Kelvin Y K Chan; Ellen P S Man; Hiroji Iwata; Shoichiro Tsugane; Hui Miao; Jiemin Liao; Yusuke Nakamura; Michiaki Kubo; Ryan J Delahanty; Yanfeng Zhang; Bingshan Li; Chun Li; Yu-Tang Gao; Xiao-Ou Shu; Daehee Kang; Wei Zheng
Journal:  Nat Genet       Date:  2014-07-20       Impact factor: 38.330

View more
  11 in total

1.  Evolutionary coupling analysis identifies the impact of disease-associated variants at less-conserved sites.

Authors:  Donghyo Kim; Seong Kyu Han; Kwanghwan Lee; Inhae Kim; JungHo Kong; Sanguk Kim
Journal:  Nucleic Acids Res       Date:  2019-09-19       Impact factor: 16.971

2.  The influence of an IL-4 variable number tandem repeat (VNTR) polymorphism on breast cancer susceptibility.

Authors:  Laith N Al-Eitan; Doaa M Rababa'h; Mansour A Alghamdi; Rame H Khasawneh
Journal:  Pharmgenomics Pers Med       Date:  2019-08-26

3.  A prognostic 4-gene expression signature for patients with HER2-negative breast cancer receiving taxane and anthracycline-based chemotherapy.

Authors:  Pu Cheng; Zhen Wang; Guoming Hu; Qi Huang; Mengjiao Han; Jian Huang
Journal:  Oncotarget       Date:  2017-10-17

4.  Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family.

Authors:  Ying Liao; Chunhua Tu; Xiaoxia Song; Liping Cai
Journal:  J Assist Reprod Genet       Date:  2020-04-30       Impact factor: 3.412

5.  PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer.

Authors:  Min Zhang; Jin Zhang
Journal:  Biosci Rep       Date:  2020-08-28       Impact factor: 3.840

6.  Identification of Variants (rs11571707, rs144848, and rs11571769) in the BRCA2 Gene Associated with Hereditary Breast Cancer in Indigenous Populations of the Brazilian Amazon.

Authors:  Elizabeth Ayres Fragoso Dobbin; Jéssyca Amanda Gomes Medeiros; Marta Solange Camarinha Ramos Costa; Juliana Carla Gomes Rodrigues; João Farias Guerreiro; José Eduardo Kroll; Sandro José de Souza; Paulo Pimentel de Assumpção; Ândrea Ribeiro-Dos-Santos; Sidney Emanuel Batista Dos Santos; Rommel Mario Rodríguez Burbano; Marianne Rodrigues Fernandes; Ney Pereira Carneiro Dos Santos
Journal:  Genes (Basel)       Date:  2021-01-22       Impact factor: 4.096

7.  Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network.

Authors:  Xiao Fan; Julia Wynn; Ning Shang; Cong Liu; Alexander Fedotov; Miranda L G Hallquist; Adam H Buchanan; Marc S Williams; Maureen E Smith; Christin Hoell; Laura J Rasmussen-Torvik; Josh F Peterson; Georgia L Wiesner; Andrea M Murad; Gail P Jarvik; Adam S Gordon; Elisabeth A Rosenthal; Ian B Stanaway; David R Crosslin; Eric B Larson; Kathleen A Leppig; Nora B Henrikson; Janet L Williams; Rongling Li; Scott Hebbring; Chunhua Weng; Yufeng Shen; Katherine D Crew; Wendy K Chung
Journal:  JNCI Cancer Spectr       Date:  2021-05-08

Review 8.  Breast cancer: Muscarinic receptors as new targets for tumor therapy.

Authors:  Alejandro Español; Agustina Salem; Yamila Sanchez; María Elena Sales
Journal:  World J Clin Oncol       Date:  2021-06-24

9.  Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer.

Authors:  Bo Chen; Guochun Zhang; Xuerui Li; Chongyang Ren; Yulei Wang; Kai Li; Hsiaopei Mok; Li Cao; Lingzhu Wen; Minghan Jia; Cheukfai Li; Liping Guo; Guangnan Wei; Jiali Lin; Yingzi Li; Yuchen Zhang; Han Han-Zhang; Jing Liu; Analyn Lizaso; Ning Liao
Journal:  Aging (Albany NY)       Date:  2020-02-24       Impact factor: 5.682

10.  Genomic Profiling Comparison of Germline BRCA and Non-BRCA Carriers Reveals CCNE1 Amplification as a Risk Factor for Non-BRCA Carriers in Patients With Triple-Negative Breast Cancer.

Authors:  Xin Huang; Di Shao; Huanwen Wu; Changbin Zhu; Dan Guo; Yidong Zhou; Chang Chen; Yan Lin; Tao Lu; Bin Zhao; Changjun Wang; Qiang Sun
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.